1. How progressive cancer endangers the heart: an intriguing and underestimated problem
   Simonetta Ausoni et al, 2020, Cancer and Metastasis Reviews CrossRef
2. Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness
   Ashley J. Smuder et al, 2020, Oncotarget CrossRef
3. The pathophysiology of cancer‐mediated cardiac cachexia and novel treatment strategies: A narrative review
   Louisa Tichy et al, 2023, Cancer Medicine CrossRef
4. Pathological features of tissues and cell populations during cancer cachexia
   Daniela Di Girolamo et al, 2022, Cell Regeneration CrossRef
5. Cardiac Complications: The Understudied Aspect of Cancer Cachexia
   Vivek Bora et al, 2022, Cardiovascular Toxicology CrossRef
6. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
   Fabrizio Pin et al, 2015, Oncotarget CrossRef
7. Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity
   Lars Michel et al, 2021, Basic Research in Cardiology CrossRef
8. Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer
   Amy A. Kirkham et al, 2019, Progress in Cardiovascular Diseases CrossRef
9. Variable body and tissue weight reporting in preclinical cachexia literature may alter study outcomes and interpretation
   Anna G. Beaudry et al, 2023, Disease Models & Mechanisms CrossRef
10. Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
    Angie M. Y. Shum et al, 2018, Oncotarget CrossRef
11. Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective
    Leslie M. Ogilvie et al, 2024, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
12. Traditional Chinese Medicine Monomers Are Potential Candidate Drugs for Cancer-Induced Cardiac Cachexia
    Zhizheng Li et al, 2024, Pharmacology CrossRef
13. Formoterol in the treatment of experimental cancer cachexia: effects on heart function
    Míriam Toledo et al, 2014, Journal of Cachexia, Sarcopenia and Muscle CrossRef
14. Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
    Yu. A. Vasyuk et al, 2021, Russian Journal of Cardiology CrossRef
15. Left ventricle- and skeletal muscle-derived fibroblasts exhibit a differential inflammatory and metabolic responsiveness to interleukin-6
    Isabell Matz et al, 2022, Frontiers in Immunology CrossRef
16. Cardiac wasting in patients with cancer
    Markus S. Anker et al, 2024, Basic Research in Cardiology CrossRef
17. Pathogenetic mechanisms of development of myocardial pathology in patients with malignant tumors: the current state of the problem
    A. G. Obrezan et al, 2020, Kardiologiia CrossRef